ArticleBMC biotechnology2025
Biodegradation of patulin in apple juice by phosphoribosyl transferase (URA5): implications for food safety.
Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patulin (PAT), a mycotoxin produced primarily by Penicillium expansum, poses significant health risks and frequently contaminates apples and apple-derived products, often exceeding permissible safety limits. This study investigated the potential of orotate phosphoribosyl transferase (URA5) to degrade PAT in apple juice under controlled conditions. PAT degradation was assessed at initial concentrations of 100 µg/L and 250 µg/L, with enzymatic treatment using 0.2 mg/mL URA5. Samples were incubated for up to 24 h, and PAT degradation was monitored at time intervals of 3, 6, 9, 12, 18, and 24 h using liquid chromatography-mass spectrometry (LC-MS). The results demonstrated a time-dependent PAT degradation, with significant reductions observed as incubation time increased. After 6 h, PAT concentrations decreased to 57.30 µg/L and 112.69 µg/L for the 100 µg/L and 250 µg/L samples, respectively. At 12 h, PAT levels in the 100 µg/L sample fell just below the permissible limit (50 µg/kg), while substantial degradation was observed in the 250 µg/L sample. By 18 h, PAT concentrations dropped further to 47.22 µg/L and 40.10 µg/L, reaching safe consumption levels. After 24 h, degradation rates reached 96.36% and 98.25%, reducing PAT levels to 30.22 µg/L and 31.48 µg/L, confirming the efficacy of URA5 in detoxifying PAT-contaminated apple juice. The findings highlight the potential application of URA5 as a biocatalyst for PAT detoxification in the fruit juice industry. Compared to existing detoxification methods, enzyme-based degradation presents a promising, environmentally friendly, cost-effective, and non-toxic alternative. Further studies should explore its feasibility in large-scale processing and its interaction with other contaminants in commercial apple juice production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.